Global Pharmaceuticals & Biotech Most Popular Stocks

GelStat

Market Cap: US$1.1m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

Intravenous Infusions

Market Cap: GH₵13.7m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

New Leaf Ventures

Market Cap: CA$1.5m

Engages in processing, packaging, marketing, and distributing cannabis and related products.

Petros Pharmaceuticals

Market Cap: US$1.1m

A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.

Ortin Global

Market Cap: ₹96.0m

Engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India.

Shamrock Industrial

Market Cap: ₹95.5m

Does not have significant operations.

VG Life Sciences

Market Cap: US$1.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

Core One Labs

Market Cap: US$1.1m

Operates as a psychedelic research and development company.

Target Group

Market Cap: US$1.0m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

AXM Pharma

Market Cap: US$1.0m

Manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.

International Stem Cell

Market Cap: US$1.0m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Premier Biomedical

Market Cap: US$1.0m

A research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases.

Unity Biotechnology

Market Cap: US$1.0m

A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

LIDDS

Market Cap: SEK 9.5m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Oxurion

Market Cap: €856.4k

A biopharmaceutical company, develops medicines to prevent blindness in Belgium.

EV Biologics

Market Cap: US$984.7k

A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

CBD of Denver

Market Cap: US$980.9k

Engages in developing and commercializing cannabidiol (CBD) products.

Hindustan Bio Sciences

Market Cap: ₹85.6m

Engages in the manufacturing and sale of pharmaceutical products in India.

RespireRx Pharmaceuticals

Market Cap: US$949.5k

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Cannovum Cannabis

Market Cap: €808.9k

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.

Alternaturals

Market Cap: US$938.2k

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs.

Nexien BioPharma

Market Cap: US$913.0k

Focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States.

Epigenomics

Market Cap: €780.5k

Does not have significant operations.

Gabather

Market Cap: SEK 8.5m

A pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases.

Vinci Gen

Market Cap: zł3.2m

Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

Mushrooms

Market Cap: US$845.9k

Mushrooms Inc. intends to acquire and merge with small, mid-size, and development stage companies focused on the mushroom industry.

Entheon Biomedical

Market Cap: CA$1.2m

Operates as a biotechnology research and development company.

NovelStem International

Market Cap: US$843.9k

A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

Quia Pharma

Market Cap: SEK 7.7m

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

Helix BioMedix

Market Cap: US$786.5k

Operates as a specialty dermatology and consumer products skin health company in the United States.

co.don

Market Cap: €668.1k

Does not have significant operations.

Pharmadrug

Market Cap: CA$1.1m

Operates as a specialty pharmaceutical company.